Correlation between trough serum levels of adalimumab and absolute PASI score in a series of patients with psoriasis
Background: The possibility of monitoring serum drug levels has opened the door to optimising biologic therapy. To consolidate this advance, it is imperative to demonstrate an adequate correlation between serum drug levels and clinical course. Objectives: To investigate whether a correlation exists...
Main Authors: | J. M. Carrascosa, M. Toro Montecinos, F. Ballescá, A. Teniente Serra, E. Martínez Cáceres, C. Ferrándiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-02-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2017.1341619 |
Similar Items
-
Usefulness and correlation with clinical response of serum ustekinumab levels measured at 6 weeks versus 12 weeks
by: M. Toro-Montecinos, et al.
Published: (2019-01-01) -
Unilateral Verrucous Psoriasis Successfully Treated With Adalimumab
by: Artur Antônio Duarte, et al.
Published: (2024-01-01) -
The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients
by: Michael Abrouk, et al.
Published: (2017-08-01) -
Diffuse large B-cell lymphoma that develops after adalimumab using adalimumab in a patient with psoriasis
by: Esra Yıldırım Bay, et al.
Published: (2021-06-01) -
Depression Over Psoriasis: Assessment of associated Relief by addition of ADalimumab for the treatment of Psoriasis: Observational study (DORADO - Ps)
by: Ayman Elgendi, et al.
Published: (2015-01-01)